Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,958 | -12,879 | -8,713 | -5,593 | -2,372 |
| Depreciation Amortization | 87 | 208 | 137 | 54 | N/A |
| Accounts payable and accrued liabilities | 123 | 283 | -29 | -36 | -38 |
| Other Working Capital | 1,124 | 1,754 | 2,242 | 3,069 | 575 |
| Other Operating Activity | 433 | 2,114 | 754 | 395 | 238 |
| Operating Cash Flow | $-1,191 | $-8,520 | $-5,609 | $-2,111 | $-1,597 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | -62 | -250 | N/A | N/A |
| Other Investing Activity | 0 | -62 | -250 | 0 | 0 |
| Investing Cash Flow | $N/A | $-62 | $-250 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 593 | 608 | 737 | 737 | N/A |
| Common Stock Issued | 10,267 | 6,283 | 132 | 1,079 | N/A |
| Other Financing Activity | 0 | -24 | 4,391 | 0 | 0 |
| Financing Cash Flow | $10,860 | $6,867 | $5,260 | $1,816 | $N/A |
| Exchange Rate Effect | 4 | -23 | -19 | 23 | 5 |
| Beginning Cash Position | 600 | 2,338 | 2,338 | 2,338 | 2,338 |
| End Cash Position | 10,273 | 600 | 1,720 | 2,066 | 746 |
| Net Cash Flow | $9,673 | $-1,738 | $-618 | $-272 | $-1,592 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,191 | -8,520 | -5,609 | -2,111 | -1,597 |
| Free Cash Flow | -1,191 | -8,520 | -5,609 | -2,111 | -1,597 |